Intuitive Surgical, Inc. $ISRG Shares Purchased by Platform Technology Partners

Key Points

• Platform Technology Partners increased its Intuitive Surgical stake by 126.9% in the third quarter, ending the period with 4,889 shares valued at about $1.99 million.
• Intuitive Surgical reported quarterly EPS of $3.00, beating the $2.65 estimate, while revenue rose 21.7% year over year to $3.05 billion. Da Vinci system placements also increased 28% year over year, though the article notes that multisystem orders and upgrades may partly explain the jump.
• Analysts’ consensus rating was Moderate Buy, with an average price target of $493.54. The shares opened at $468.52, and recent director share sales were made under pre-arranged trading plans.

Platform Technology Partners grew its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 126.9% in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 4,889 shares of the medical equipment provider's stock after buying an additional 2,734 shares during the quarter. Platform Technology Partners' holdings in Intuitive Surgical were worth $1,988,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently made changes to their positions in the stock. Beaumont Financial Advisors LLC lifted its position in Intuitive Surgical by 3.8% in the 3rd quarter. Beaumont Financial Advisors LLC now owns 627 shares of the medical equipment provider's stock valued at $255,000 after acquiring an additional 23 shares in the last quarter. Hughes Financial Services LLC increased its holdings in Intuitive Surgical by 40.7% during the 3rd quarter. Hughes Financial Services LLC now owns 83 shares of the medical equipment provider's stock worth $37,000 after purchasing an additional 24 shares in the last quarter. W.G. Shaheen & Associates DBA Whitney & Co increased its holdings in Intuitive Surgical by 1.0% during the 1st quarter. W.G. Shaheen & Associates DBA Whitney & Co now owns 2,542 shares of the medical equipment provider's stock worth $1,172,000 after purchasing an additional 25 shares in the last quarter. Blue Fin Capital Inc. increased its holdings in Intuitive Surgical by 0.5% during the 1st quarter. Blue Fin Capital Inc. now owns 4,794 shares of the medical equipment provider's stock worth $2,210,000 after purchasing an additional 25 shares in the last quarter. Finally, Red Spruce Capital LLC raised its stake in shares of Intuitive Surgical by 4.1% in the 2nd quarter. Red Spruce Capital LLC now owns 640 shares of the medical equipment provider's stock valued at $255,000 after purchasing an additional 25 shares during the period. Institutional investors and hedge funds own 83.64% of the company's stock.

Intuitive Surgical Trading Down 2.8%

Shares of ISRG opened at $468.52 on Friday. Intuitive Surgical, Inc. has a 12 month low of $328.57 and a 12 month high of $603.88. The firm has a fifty day simple moving average of $408.22 and a 200 day simple moving average of $432.27. The stock has a market capitalization of $162.41 billion, a price-to-earnings ratio of 56.65, a PEG ratio of 3.32 and a beta of 1.45.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its quarterly earnings results on Tuesday, October 20th. The medical equipment provider reported $3.00 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.65 by $0.35. Intuitive Surgical had a net margin of 25.54% and a return on equity of 18.17%. The firm had revenue of $3.05 billion for the quarter, compared to analyst estimates of $2.91 billion. During the same period in the previous year, the business earned $2.40 EPS. The company's revenue was up 21.7% compared to the same quarter last year. As a group, research analysts predict that Intuitive Surgical, Inc. will post 9.37 earnings per share for the current fiscal year.

Key Headlines Impacting Intuitive Surgical

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Da Vinci system placements rose 28% year over year to 546 in Q3 2026, while net placements increased 40%, pointing to continued demand for Intuitive Surgical’s robotic-surgery systems and expansion of its installed base. Article: ISRG System Placements Rise 28%
• Neutral Sentiment: The placements increase may reflect multisystem orders and upgrades, rather than a broad-based upswing in hospital capital-equipment budgets. That leaves open whether the strong pace can be sustained. Article: ISRG System Placements Rise 28%: Is Capital Equipment Demand Rising?
• Negative Sentiment: Two directors disclosed share sales: Gary Guthart sold 10,000 shares (0.83% of his position), and Craig Barratt sold 1,150 shares. Both transactions were made under pre-arranged Rule 10b5-1 plans, which may temper—but not eliminate—their significance as a sentiment overhang. SEC filing: Gary Guthart transaction SEC filing: Craig Barratt transaction

Wall Street Analysts Forecast Growth

A number of brokerages have recently commented on ISRG. Weiss Ratings restated a "hold (c)" rating on shares of Intuitive Surgical in a report on Friday, August 14th. Piper Sandler reaffirmed an "overweight" rating on shares of Intuitive Surgical in a research report on Friday, August 21st. Erste Group Bank upgraded Intuitive Surgical from a "hold" rating to a "buy" rating in a report on Wednesday, October 21st. Wells Fargo & Company reissued an "overweight" rating and issued a $486.00 target price (down from $487.00) on shares of Intuitive Surgical in a research report on Wednesday, October 21st. Finally, KeyCorp restated an "overweight" rating on shares of Intuitive Surgical in a research note on Wednesday, August 12th. One analyst has rated the stock with a Strong Buy rating, twenty-three have issued a Buy rating, five have assigned a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, Intuitive Surgical currently has a consensus rating of "Moderate Buy" and an average price target of $493.54.

Insider Activity at Intuitive Surgical

In other news, Director Amy Ladd sold 400 shares of the firm's stock in a transaction dated Monday, August 10th. The stock was sold at an average price of $379.00, for a total value of $151,600.00. Following the completion of the transaction, the director owned 251 shares in the company, valued at $95,129. This trade represents a 61.44% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, SVP Patricia Wadors sold 1,078 shares of the firm's stock in a transaction dated Friday, October 23rd. The shares were sold at an average price of $443.80, for a total value of $478,416.40. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last 90 days, insiders sold 49,928 shares of company stock worth $21,917,367. Corporate insiders own 0.60% of the company's stock.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops and manufactures robotic-assisted systems and related technologies for minimally invasive surgery. Its products are designed to help surgeons perform procedures through small incisions while providing enhanced visualization, precision and control. The company's primary platform is the da Vinci Surgical System, which is used across a range of specialties, including urology, gynecology, general surgery, cardiothoracic surgery and other procedures.

The company also offers the Ion endoluminal system, which is designed to support minimally invasive lung biopsy procedures.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.